Tags

Type your tag names separated by a space and hit enter

[Long-term treatment of senile macular degeneration with Cosaldon A+E].

Abstract

During the early phase of senile degeneration of the macula treatment with Cosaldon A+E offers real changes of improvement. In the later phases long-term Cosaldon therapy can bring about an appreciable improvement when other vasoactive substances are administered at intervals. The addition of the vitamins A and E improves the efficacy of Cosaldon. Results in 157 patients are supported by statistics.

Links

  • Publisher Full Text
  • Authors

    Source

    MeSH

    Adult
    Aged
    Drug Combinations
    Drug Therapy, Combination
    Female
    Humans
    Long-Term Care
    Macular Degeneration
    Male
    Middle Aged
    Nicotinic Acids
    Theobromine
    Visual Acuity
    Vitamin A
    Vitamin E

    Pub Type(s)

    English Abstract
    Journal Article

    Language

    ger

    PubMed ID

    3934458

    Citation

    Stark, H. "[Long-term Treatment of Senile Macular Degeneration With Cosaldon A+E]." Klinische Monatsblatter Fur Augenheilkunde, vol. 187, no. 4, 1985, pp. 296-302.
    Stark H. [Long-term treatment of senile macular degeneration with Cosaldon A+E]. Klin Monbl Augenheilkd. 1985;187(4):296-302.
    Stark, H. (1985). [Long-term treatment of senile macular degeneration with Cosaldon A+E]. Klinische Monatsblatter Fur Augenheilkunde, 187(4), pp. 296-302.
    Stark H. [Long-term Treatment of Senile Macular Degeneration With Cosaldon A+E]. Klin Monbl Augenheilkd. 1985;187(4):296-302. PubMed PMID: 3934458.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - [Long-term treatment of senile macular degeneration with Cosaldon A+E]. A1 - Stark,H, PY - 1985/10/1/pubmed PY - 1985/10/1/medline PY - 1985/10/1/entrez SP - 296 EP - 302 JF - Klinische Monatsblatter fur Augenheilkunde JO - Klin Monbl Augenheilkd VL - 187 IS - 4 N2 - During the early phase of senile degeneration of the macula treatment with Cosaldon A+E offers real changes of improvement. In the later phases long-term Cosaldon therapy can bring about an appreciable improvement when other vasoactive substances are administered at intervals. The addition of the vitamins A and E improves the efficacy of Cosaldon. Results in 157 patients are supported by statistics. SN - 0023-2165 UR - https://www.unboundmedicine.com/medline/citation/3934458/[Long_term_treatment_of_senile_macular_degeneration_with_Cosaldon_A+E]_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1054317 DB - PRIME DP - Unbound Medicine ER -